Phoenix Education Partners, Inc. filed a Form 8-K on November 12, 2026, disclosing that its Board of Directors declared a special cash dividend of $2.36 per share on November 11, 2026.
PVH Corp. filed an 8-K on November 12, 2026, disclosing the launch of a global enterprise-wide restructuring initiative aimed at simplifying operations, reducing its workforce by approximately 4%, and achieving at least $150 million in annualized net pre-tax cost savings beginning in fiscal 2028.
Cohen & Company Inc. filed a Form 8-K on November 12, 2026, reporting the November 9, 2026 resignation of Chief Executive Officer Lester R. Brafman and the appointment of Executive Chairman Daniel G. Cohen as his successor, effective November 10, 2026.
Hancock Whitney Corporation filed an 8-K on November 12, 2026, disclosing the execution of an Agreement and Plan of Merger with Trustmark Corporation, under which Trustmark will merge with and into Hancock Whitney, with Hancock Whitney continuing as the surviving corporation.
HubSpot, Inc. filed a current report on November 12, 2026, disclosing simultaneous changes to its top two executive positions, including the return of co-founder Brian Halligan as President and Chief Executive Officer and the appointment of Karen Burgess as incoming Chief Financial Officer.
Cohen & Company Inc. filed a Form 8-K on November 12, 2026, reporting the issuance of a press release announcing its financial results for the third quarter ended September 30, 2026.
The Western Union Company filed a Form 8-K on November 12, 2026, disclosing the termination of its Agreement and Plan of Merger with International Money Express, Inc. (IMXI), effective 12:00 a.m. Eastern time on November 12, 2026, following unacceptable regulatory conditions issued by California's …
Profound Medical Corp. filed an 8-K on November 12, 2026, disclosing a series of leadership changes effective November 5, 2026, including a planned CEO transition, a new CFO appointment, a director resignation and replacement, and amendments to its non-employee director compensation policy.
Prime Medicine, Inc. filed a Form 8-K on November 12, 2026, disclosing an underwritten public offering of 35,714,286 shares of common stock at $3.50 per share, with an Underwriting Agreement entered into on November 10, 2026.
Health In Tech, Inc. filed a Form 8-K on November 12, 2026, reporting the voting results from its 2026 Annual Meeting of Stockholders held on November 10, 2026, at which stockholders approved all five proposals submitted to a vote.